- The Innovation Hub located in Songdo, Incheon will encompass a manufacturing facility and customer experience lab.
- Operations of the manufacturing facility are anticipated to begin in 2026, with a focus on producing high-quality filtration products.
September 30, 2024
Cytiva, a global life sciences leader, has opened its first Innovation Hub in Korea, located in the Songdo Bio-cluster in Incheon.
The new facility is intended to serve as a cornerstone of innovation and excellence, driving advancements in biopharmaceutical manufacturing and meeting the evolving needs of Cytiva customers in Korea and the wider APAC region.
An opening event on 30 September was attended by key government officials from the Incheon Free Economic Zone Authority (IFEZ), and the Korea Trade‐Investment Promotion Agency (KOTRA). Cytiva leaders and other executives from industry leading companies such as Samsung Biologics, Samsung Bioepis, Celltrion, SK bioscience and Lotte Biologics were also present.
From left to right: Joonho Choi (General Manager, Cytiva Korea), Jung Tae Park (Vice President, Korea Biomedicine Industry Association), Seung Kyou Lee (Vice President, Korea Biotechnology Industry Organization), Maria Khoury (CFO, Cytiva), Christopher Riley (CEO, Cytiva), Won-sok Yun (Commissioner, Incheon Free Economic Zone), Sung Joon Ahn (Director General, Consumer Goods & Bio Medical Department at Korea Trade-Investment Promotion Agency), Ed Hoare (Vice President and General Manager for Filtration, Cytiva), Rajan Sankaran (General Manager, Bioprocess Asia-Pacific, Cytiva)
Won-sok Yun, Commissioner of the Incheon Free Economic Zone (IFEZ), says: "With Cytiva’s Innovation Hub, Songdo enhances its position as a world bio hub. We will continue to work with Cytiva to explore ways to drive the growth of the domestic bio industry, including the training of bio professionals."
Jongkyu Yoon, vice president of Samsung Biologics says: “In light of growing demand for biopharmaceuticals, the opening of Cytiva's production facility in Korea is great news for pharmaceutical and biotech companies. I am confident that our close collaboration with Cytiva through this Innovation Hub will significantly boost the competitiveness of our domestic life sciences industry.”
A new era of innovation and collaboration
Spanning approximately 6 100 square meters, the Innovation Hub features a manufacturing facility to deliver the necessary products used in developing therapeutics, and a customer experience lab for product demonstrations.
In line with Cytiva’s commitment to sustainability, the facility will adhere to Net-Zero environmental impact standards. This will involve the integration of various sustainable building practices aimed at increasing energy and water efficiencies, achieving zero landfilling of waste, and reducing CO2e emissions.
Joonho Choi, Commercial General Manager of Cytiva Korea, says: " We anticipate the Innovation Hub will not only help drive growth for our Korean customers, but also play a pivotal role in the APAC biopharmaceutical market. This facility will enhance customer engagement and collaboration, fostering innovation and excellence in the region."
Strengthening Korea’s biopharma industry and beyond
This new facility is a key component of Cytiva’s comprehensive strategy to address the increasing demands of the biopharmaceutical industry in Korea and the broader APAC region.
By adopting sustainable building practices, Cytiva aims to provide Korean customers with eco-friendly solutions that drive industry growth, benefit the market, and support environmental goals.
For more information about Cytiva’s sustainability efforts please visit here.
About Cytiva
At Cytiva, our mission is to advance and accelerate the development of therapeutics. With 15 000 associates in more than 40 countries, we’re driven to use our expertise and talent to achieve better flexibility, capacity, and efficiency for our customers. Our broad and deep portfolio of tools and technologies, global scale, and best-in-class service provides critical support from discovery to delivery, for customers spanning researchers, emerging biotech, large-scale biopharma and contract manufacturers.
Learn more at cytivalifesciences.com
Media Contact:
Doug Kim
[email protected]